Diagnostics

New Data at ASCO 2025 Affirms DecisionDx®-Melanoma’s Ability to Improve Upon Staging-Based Risk Stratification and Predict Survival Outcomes

Study results show that DecisionDx-Melanoma was associated with a 32% reduction in mortality risk compared to untested patientsFRIENDSWOOD, Texas, May...

SECTRA EQUIPS MULTI-SITE US HEALTH SYSTEM WITH ENTERPRISE IMAGING AS A CLOUD SERVICE AND ACCELERATES AI ADOPTION FOR IMPROVED PATIENT DIAGNOSTICS

SHELTON, Conn., May 28, 2025 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) will provide a US...

CorePlus Puerto Rico Publishes Groundbreaking Study on Implementing 100% Quality Control in Cervical Cytology Using Whole Slide Imaging and Artificial Intelligence

CAROLINA, Puerto Rico, May 27, 2025 /PRNewswire/ -- CorePlus, a leading precision pathology organization in Puerto Rico, has announced the...

MOBILion Systems to Highlight Customer Use Cases from its MOBIE® Platform and Unveil Plans for their Next Generation Proteomics Platform at ASMS 2025

CHADDS FORD, Pa., May 27, 2025 /PRNewswire/ -- MOBILion Systems, Inc., a leader in separation science innovation, will attend and...

CHMP recommends EU approval of Roche’s Itovebi for PIK3CA-mutated, ER-positive, HER2-negative, advanced breast cancer

Positive recommendation based on phase III INAVO120 data showing ItovebiTM (inavolisib) in combination with palbociclib and fulvestrant more than doubled...

error: Content is protected !!